⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VBIO News
Valion Bio, Inc. Common Stock
Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Form 8-K
sec.gov
VBIO
Form 8-K
sec.gov
VBIO
Form 8-K
sec.gov
VBIO
Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Valion Bio Announces Positive Safety Results From U.S. Government-Funded Entolimod Study, Paving Way For Therapeutic Efficacy Evaluation
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options
accessnewswire.com
VBIO